Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
HKEX:6826
Hong Kong Market
6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
RESEARCH TOOLSreports
Holding HK:6826?
Track your performance easily

Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) Stock Price & Analysis

0 Followers

6826 Stock Chart & Stats


Options Prices

Currently, No data available
---

Ownership Overview

3.48%92.93%
Insiders
― Other Institutional Investors
92.93% Public Companies and
Individual Investors

6826 FAQ

What was Shanghai Haohai Biological Technology Co., Ltd. Class H’s price range in the past 12 months?
Shanghai Haohai Biological Technology Co., Ltd. Class H lowest stock price was HK$21.71 and its highest was HK$42.95 in the past 12 months.
    What is Shanghai Haohai Biological Technology Co., Ltd. Class H’s market cap?
    Currently, no data Available
    When is Shanghai Haohai Biological Technology Co., Ltd. Class H’s upcoming earnings report date?
    Shanghai Haohai Biological Technology Co., Ltd. Class H’s upcoming earnings report date is Mar 26, 2025 which is in 136 days.
      How were Shanghai Haohai Biological Technology Co., Ltd. Class H’s earnings last quarter?
      Shanghai Haohai Biological Technology Co., Ltd. Class H released its earnings results on Oct 26, 2024. The company reported HK$0.493 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.493.
        Is Shanghai Haohai Biological Technology Co., Ltd. Class H overvalued?
        According to Wall Street analysts Shanghai Haohai Biological Technology Co., Ltd. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Shanghai Haohai Biological Technology Co., Ltd. Class H pay dividends?
          Shanghai Haohai Biological Technology Co., Ltd. Class H pays a Annually dividend of HK$0.44 which represents an annual dividend yield of 3.86%. See more information on Shanghai Haohai Biological Technology Co., Ltd. Class H dividends here
            What is Shanghai Haohai Biological Technology Co., Ltd. Class H’s EPS estimate?
            Shanghai Haohai Biological Technology Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Shanghai Haohai Biological Technology Co., Ltd. Class H have?
            Shanghai Haohai Biological Technology Co., Ltd. Class H has 40,138,440 shares outstanding.
              What happened to Shanghai Haohai Biological Technology Co., Ltd. Class H’s price movement after its last earnings report?
              Shanghai Haohai Biological Technology Co., Ltd. Class H reported an EPS of HK$0.493 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.616%.
                Which hedge fund is a major shareholder of Shanghai Haohai Biological Technology Co., Ltd. Class H?
                Currently, no hedge funds are holding shares in HK:6826
                ---

                Shanghai Haohai Biological Technology Co., Ltd. Class H Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                5.00%
                12-Months-Change

                Fundamentals

                Return on Equity
                7.52%
                Trailing 12-Months
                Asset Growth
                5.52%
                Trailing 12-Months

                Company Description

                Shanghai Haohai Biological Technology Co., Ltd. Class H

                Shanghai Haohai Biological Technology Co Ltd is engaged in manufacturing and sale of biologicals, medical hyaluronate, ophthalmology products. It is also engaged in the research and development of biological engineering, pharmaceutical and ophthalmology products, and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Aoyuan Healthy Life Group Co. Ltd.
                Essex Bio-Technology
                Dragon Rise Group Holdings Ltd.
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis